1279 related articles for article (PubMed ID: 33579329)
1. Challenges and advances in clinical applications of mesenchymal stromal cells.
Zhou T; Yuan Z; Weng J; Pei D; Du X; He C; Lai P
J Hematol Oncol; 2021 Feb; 14(1):24. PubMed ID: 33579329
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application.
Allan D; Tieu A; Lalu M; Burger D
Stem Cells Transl Med; 2020 Jan; 9(1):39-46. PubMed ID: 31411820
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19.
Xiong J; Chen L; Zhang L; Bao L; Shi Y
Cell Transplant; 2021; 30():963689721995455. PubMed ID: 33650894
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
6. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis.
Liu H; Li R; Liu T; Yang L; Yin G; Xie Q
Front Immunol; 2020; 11():1912. PubMed ID: 32973792
[TBL] [Abstract][Full Text] [Related]
7. Advancing Mesenchymal Stem Cell Therapy with CRISPR/Cas9 for Clinical Trial Studies.
Golchin A; Shams F; Karami F
Adv Exp Med Biol; 2020; 1247():89-100. PubMed ID: 31974923
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?
Muraca M; Pessina A; Pozzobon M; Dominici M; Galderisi U; Lazzari L; Parolini O; Lucarelli E; Perilongo G; Baraldi E
J Control Release; 2020 Sep; 325():135-140. PubMed ID: 32622963
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
Kahmini FR; Shahgaldi S
Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles.
Gómez-Ferrer M; Villanueva-Badenas E; Sánchez-Sánchez R; Sánchez-López CM; Baquero MC; Sepúlveda P; Dorronsoro A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810359
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells: Biological characteristics and application in disease therapy.
Lou S; Duan Y; Nie H; Cui X; Du J; Yao Y
Biochimie; 2021 Jun; 185():9-21. PubMed ID: 33711361
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
Tufan AC
Curr Stem Cell Res Ther; 2021; 16(4):465-480. PubMed ID: 33238848
[TBL] [Abstract][Full Text] [Related]
13. Functionally engineered extracellular vesicles improve bone regeneration.
Huang CC; Kang M; Lu Y; Shirazi S; Diaz JI; Cooper LF; Gajendrareddy P; Ravindran S
Acta Biomater; 2020 Jun; 109():182-194. PubMed ID: 32305445
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options.
Mello DB; Mesquita FCP; Silva Dos Santos D; Asensi KD; Dias ML; Campos de Carvalho AC; Goldenberg RCDS; Kasai-Brunswick TH
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892249
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.
Galipeau J; Sensébé L
Cell Stem Cell; 2018 Jun; 22(6):824-833. PubMed ID: 29859173
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
[No Abstract] [Full Text] [Related]
17. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
[TBL] [Abstract][Full Text] [Related]
18. Genetically Engineered-MSC Therapies for Non-unions, Delayed Unions and Critical-size Bone Defects.
Freitas J; Santos SG; Gonçalves RM; Teixeira JH; Barbosa MA; Almeida MI
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336890
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of Mesenchymal Stromal Cells: Finding the Right Route to Therapy.
Wilson A; Hodgson-Garms M; Frith JE; Genever P
Front Immunol; 2019; 10():1112. PubMed ID: 31164890
[TBL] [Abstract][Full Text] [Related]
20. Regeneration-Related Functional Cargoes in Mesenchymal Stem Cell-Derived Small Extracellular Vesicles.
Zhu Z; Zhang Y; Wu L; Hua K; Ding J
Stem Cells Dev; 2020 Jan; 29(1):15-24. PubMed ID: 31691632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
